Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
Medical College of Wisconsin
Essen Biotech
Big Ten Cancer Research Consortium
University of Michigan Rogel Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
Essen Biotech
Cancer Research UK
Georgetown University
City of Hope Medical Center
M.D. Anderson Cancer Center
Mayo Clinic
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
Mayo Clinic
Stanford University
University Hospital Heidelberg
Peter MacCallum Cancer Centre, Australia
AHS Cancer Control Alberta
University of Chicago
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
University of Nebraska
OHSU Knight Cancer Institute
Massachusetts General Hospital
City of Hope Medical Center
Columbia University
City of Hope Medical Center
Mayo Clinic
Chinese PLA General Hospital
Louisiana State University Health Sciences Center Shreveport
Mayo Clinic
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
Mayo Clinic
Northwestern University
Swiss Cancer Institute
Chinese PLA General Hospital
Xinqiao Hospital of Chongqing
Memorial Sloan Kettering Cancer Center
Lymphoma Study Association
Weill Medical College of Cornell University
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota